ロード中...
Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo
Background: In clinical practice, common problem polypharmacy could result in the increased risks of drug–drug interactions (DDIs). Co-administered imatinib (IMA) and voriconazole (VOR) as one treatment protocol in cancer patients with fungal infections are common.Purpose: The aim of the present stu...
保存先:
| 出版年: | Infect Drug Resist |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6502443/ https://ncbi.nlm.nih.gov/pubmed/31118708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S199526 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|